Advertisement
U.S. markets open in 5 hours 27 minutes

T2 Biosystems, Inc. (TTOO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
5.05-0.25 (-4.72%)
At close: 04:00PM EST
5.20 +0.15 (+2.97%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close5.30
Open5.25
Bid0.00 x 1100
Ask0.00 x 800
Day's Range5.01 - 5.25
52 Week Range3.36 - 70.00
Volume99,388
Avg. Volume367,728
Market Cap20.454M
Beta (5Y Monthly)0.12
PE Ratio (TTM)N/A
EPS (TTM)-35.62
Earnings DateMay 21, 2024 - May 28, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TTOO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • T2 Biosystems, Inc.
    BRKR: Raising target price to $85.00BRUKER CORP has an Investment Rating of HOLD; a target price of $85.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
  • Insider Monkey

    T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript

    T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript February 15, 2024 T2 Biosystems, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone. And welcome to the T2 Biosystems Preliminary Fourth Quarter and Full Year 2023 Results […]

  • Thomson Reuters StreetEvents

    Q4 2023 T2 Biosystems Inc Earnings Call

    Q4 2023 T2 Biosystems Inc Earnings Call

  • GlobeNewswire

    T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results

    Advanced multiple new products and achieved record fourth quarter U.S. T2Bacteria Panel salesLEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial and operational results for the fourth quarter and full year ended December 31, 2023. Full Year 2023 and Recent Commercial Highlights Achieved full year 2023 total